Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population

BMC Neuroscience volume 15, Article number: 127 (2014) Cite this article

Abstract

Background

Individuals with Williams syndrome, a neurogenetic condition caused by deletion of a set of genes at chromosomal location 7q11.23, exhibit a remarkable suite of traits including hypersociality with high, nonselective friendliness and low social anxiety, expressive language relatively well-developed but under-developed social-communication skills overall, and reduced visual-spatial abilities. Deletions and duplications of the Williams-syndrome region have also been associated with autism, and with schizophrenia, two disorders centrally involving social cognition. Several lines of evidence have linked the gene GTF2I (General Transcription Factor IIi) with the social phenotypes of Williams syndrome, but a role for this gene in sociality within healthy populations has yet to be investigated.

Results

We genotyped a large set of healthy individuals for two single-nucleotide polymorphisms in the GTF2I gene that have recently been significantly associated with autism, and thus apparently exhibit functional effects on autism-related social phenotypes. GTF2I genotypes for these SNPs showed highly significant association with low social anxiety combined with reduced social-communication abilities, which represents a metric of the Williams-syndrome cognitive profile as described from previous studies.

Conclusions

These findings implicate the GTF2I gene in the neurogenetic basis of social communication and social anxiety, both in Williams syndrome and among individuals in healthy populations.

Background

A promising approach to elucidating the genetic bases of human social behavior is the study of well-defined genetic or genomic variation with specific cognitive, behavioral and neurological effects. Williams syndrome represents a paradigmatic neurogenetic condition for such analyses, as it is caused by hemizygous deletion (loss of one copy, from the normal diploid complement of two copies) of about 25 genes at 7q11.23, and its social cognitive-behavioral profile has been thoroughly characterized as involving hypersociality and low social anxiety with high, nonselective friendliness, expressive language relatively well-developed but social-communication skills reduced overall, high levels of non-social anxiety, and notably-reduced visual-spatial abilities [1]-[7]. In contrast to these effects of gene deletion in Williams syndrome, duplication of the same set of genes has been associated with a directly-contrasting cognitive-behavioral profile of selectively-underdeveloped expressive language and high levels of separation anxiety [8]-[10]. These findings suggest the presence of dosage-sensitive genes in the Williams-syndrome region that affect anxiety, language and social behavior in two opposite directions, in individuals with this syndrome as well as in healthy populations. Imaging studies of individuals with Williams syndrome provide evidence that these cognitive and behavioral phenotypes are mediated by abnormalities in the insula, orbitofrontal cortex and amygdala, with reduced amygdala activation to threatening faces, abnormal orbitofrontal modulation of social inhibition and engagement, and altered structure and function in regions of the insula that are correlated with measures of the Williams syndrome personality profile [11]-[13].

Genes mediating cognitive-behavioral phenotypes in 7q11.23 deletions and duplications have been identified in several ways. First, the cognitive-behavioral profiles of individuals with small, atypical deletions in this region have implicated the GTF2I gene in hypersociality [14],[15]. Variable-sized deletions have also been generated in mouse models, which have implicated the region including GTF2I, GTF2IRD1, LIMK1, and intervening genes, in sociality and anxiety phenotypes [16].

Second, mouse single-gene knockouts have indicated that GTF2I gene dosages modulate levels of sociality, with hemizygosity leading to higher levels of less-discriminate social interaction [17], and triploidy, which corresponds to the duplication, being associated with higher social anxiety [9].

Third, studies of segregating genetic variation for genes within the Williams-syndrome deletion region have identified an association of several SNPs in GTF2I with autism [18]. These results are of notable interest given reports of autism spectrum behavior in individuals with Williams syndrome [19]-[21], and evidence for association of duplications for this 7q11.23 region with autism in case–control studies of (predominantly) children [22]. Duplications of this 7q11.23 region have also recently been associated with increased risk of schizophrenia (in adults) [23]. Links of Williams-syndrome region genes and CNVs with autism and schizophrenia suggest that the phenotypes constituting these disorders may be relevant to those of individuals with 7q11.23 deletions and duplications.

Taken together, these lines of evidence regarding the causes of the Williams syndrome region cognitive-behavioral phenotypes suggest important roles for the GTF2I gene. One approach to uncovering these roles is to evaluate the cognitive-behavioral effects of polymorphisms in the GTF2I gene in healthy populations, which have yet to be investigated. In this study, we have tested for association of the two autism-associated SNPs in the GTF2I gene [18] with a set of autism-associated and schizophrenia-associated psychological phenotypes as defined by and derived from subscales of the Autism Quotient (AQ) [24] and the Schizotypal Personality Questionnaire - Brief Revised (SPQ) [25].

From the SPQ, we analyzed variation in the Social Anxiety subscale, which quantifies a core phenotype associated with the Williams-syndrome region (low versus high social anxiety). From the AQ, we analyzed the Communication and Social subscales, based on the well-documented social-interactive phenotypes of Williams syndrome, and the previously-established association of these two SNPs with autism [18]. We predicted that these previously-established autism-associated alleles and genotypes of GTF2I [18] should be associated with higher scores for these two measures.

We also constructed a metric of Social Anxiety relative to Communication, based on a conceptual model of Williams syndrome developed by Reilly et al. [26],[27] and Fishman et al. [28], which posits that language and conversation skills, and drive for social approach and engagement, are jointly fundamental to the Williams syndrome cognitive-behavioral phenotypes. We constructed this metric by scaling the Communication subscale, and the Social Anxiety subscale, each to between 0 and 1 through dividing by the highest value of each (to equalize their ranges and relative contributions to the score). We then reversed the Social Anxiety score (by subtracting it from 1), and added this modified Social Anxiety score to the Communication score. For this variable, relatively high values thus represent relatively low social anxiety combined with reduced adaptive social-communicative abilities, which can be regarded as the cognitive-behavioral combination most-closely characteristic of Williams syndrome, from previous studies [6],[7],[29]. This metric is referred to here as Williams syndrome profile score, and we predicted that higher scores should be associated with the autism-associated alleles and genotypes [18]. Finally, we analyzed GTF2I genotypes in relation to total Autism score from the AQ, and total Schizotypy score from the SPQ, based on the associations of copy number variants in this region with autism and schizophrenia [22],[23], and the studies linking Williams syndrome with some autistic traits as discussed above. For these metrics, we predicted that total Autism scores should be higher for individuals with the autism-associated alleles or genotypes [18], and that the alternative alleles or genotypes should be associated with total Schizotypy. This prediction is predicated on a model whereby the GTF2I genotypes analyzed here are associated with alterations to GTF2I gene dosage or activity in some way (as evidenced by [18]), in a manner that is comparable, but considerably less pronounced, to the opposite alterations observed in CNV deletions and duplications. Comparable subclinical effects of genetic variants have been described previously for CNVs mediating risk of autism and schizophrenia [30].

Methods

Populations and sampling

Questionnaire data and saliva samples used for DNA extraction were collected from Caucasian undergraduate students at the University of Alberta and Simon Fraser University (311 females and 177 males). All protocols were carried out according to guidelines established by ethics boards of the both universities (Simon Fraser University Office of Research Ethics, Permit 2010 s0554, and University of Alberta Arts, Science and Law Research Ethics Board, Permit Pro00015728), and all participants provided informed consent. Given the low frequencies of Williams syndrome region deletions (1 in about 10,000-20,000 births [2],[4]) and duplications (1 in over 20,000 births) [23], and the fact that both CNVs engender penetrant phenotypes that are readily ascertained in early childhood, it is exceedingly unlikely that anyone in our sample population harbored either of these CNVs.

Questionnaire data and analyses

Schizotypy was measured using the Schizotypal Personality Questionnaire-Brief Revised (SPQ-BR), autistic phenotypes were measured using the Autism Spectrum Quotient (AQ). From the AQ, we analyzed the Social skills and Communication subscales, in accordance with the social and communication dimensions of Williams syndrome phenotypes.

SNP genotype data and analyses

Genomic DNA was extracted from mouthwash samples that were provided by each participant, and stored at -20C. Genotyping was conducted on two SNPs in GTF2I (rs4717907 and rs13227433). These two GTF2I SNPs were chosen for genotyping because their common alleles were significantly associated with autism by Malenfant et al. [18]. Genotyping was performed by Genome Québec (Montréal, Canada) using the Sequenom Mass-ARRAY iPlex platform. The two GTF2I SNPs were in high linkage disequilibrium (r2 = 0.94), which is consistent with LD results from SNAP Pairwise LD analysis of 1000 genomes CEU data (Broad Institute 2008, http://www.broadinstitute.org/mpg/snap/ldsearchpw.php). Genotype data were analyzed using ANOVA and under two alternative models of gene action with regard to allelic dominance. Haplotype-based analysis using hapassoc [31] yielded essentially equivalent results to analyses using each marker separately. Statistical analyses were performed using R, version 2.15.1. Both markers were in Hardy-Weinberg equilibrium (χ 2 = 0.73 for rs4717907, 0.55 for rs13227433, P >0.05 for both).

Results

The means and standard deviations for each of the variables analyzed are presented in Table 1, and ANOVA significance values under alternative genetic models of dominance, codominance and recessiveness are provided in Table 2. Under a codominant model, genotypes of the GTF2I single nucleotide polymorphisms rs4717907 and rs13227433 were not significantly different by ANOVA for the Social, Communication, or Social Anxiety subscale scores, or for total Autism or total Schizotypy, although the differences for Communication (for rs13227433) and for Social Anxiety (for both SNPs) approached significance (0.05 < P <0.10) (Table 1). By contrast, Williams syndrome profile scores (measuring high AQ-Communication in combination with low SPQ-Social Anxiety) were highly significantly different between genotype groups under the codominant model (P = 0.0053 for rs4717907 and P = 0.0069 for rs13227433) (Table 1). Individuals with the common (autism-associated) alleles and genotypes thus showed higher scores on this profile, which indicates lower Social Anxiety combined with higher Communication scores (i. e., reduced communication abilities).

Table 1 Means and standard deviations (in parentheses) for the different SNP genotypes of GTF2I
Full size table
Table 2 P-values from ANOVAs comparing mean values of psychological variables between genotypes
Full size table

Variation in GTF2I genotypes for rs4717907 and rs13227433 was nominally associated with Social Anxiety under a dominant model (P = 0.04 for each), and rs13227433 genotype was nominally associated with Communication under a recessive model (P = 0.03) (Tables 1 and 2). Under a dominant model, there were highly significant differences between genotypes for the Williams syndrome profile score (Tables 1 and 2); under a recessive model, rs13227433 showed nominal significance for this metric, and rs4717907 showed marginal non-significance. There were no associations between GTF2I genotypes and the other variables under either model, although the association of rs13227433 with total Autism approached significance (P = 0.08) under a recessive model.

Discussion

Our results demonstrate significant associations of Williams syndrome cognitive-behavioral phenotypes with autism-associated SNP polymorphisms in the GTF2I gene. In particular, especially under codominant and dominant models, GTF2I genotypes were strongly associated with the Williams syndrome profile metric of low Social Anxiety scores (which are indicative of relatively high social motivation) combined with high Communication scores (which are indicative of relatively ‘autistic’ phenotypes as regards conversational interactions). These results are thus consistent with the hypothesis that high social approach motivation (and concomitant lower levels of fear and anxiety in social contexts), coupled with reduced social-interactive abilities, represent a central aspect of Williams syndrome cognitive-behavioral phenotypes [26]-[28], and specifically implicate genetic variation in the GTF2I gene in this phenotype. In this context, our results from a healthy population are compatible with multiple independent lines of evidence on the role of GTF2I in mediating social phenotypes of Williams syndrome, including data from both mouse models and genotype-phenotype correlations of individuals with atypical deletions, as described in more detail above. Our data thus also implicate GTF2I in the neurological basis of social behavior in Williams syndrome, based on documented alterations to activation and integration of the insula, orbitofrontal cortex and amygdala in this syndrome [11]-[13], although this hypothesis requires targeted study using imaging genetics of individuals who differ in genotype for rs4717907 and rs13227433.

Our findings also provide independent support, in a healthy population, for the demonstration by Malefant et al. [18] that the SNPs rs4717907 and rs13227433 show functional associations with phenotypes that are highly relevant to Williams syndrome, and extend these results by showing association with a more-specific phenotype that was predicted from previous studies [26]-[28] to characterize behavior in this syndrome. As such, these results provide convergent evidence for behavioral-genetic continuity between the effects of these GTF2I polymorphisms in Williams syndrome, autism, and healthy populations, and indicate that functional characterization of the effects of these SNPs should provide insights into the genetic bases of variation in human social cognition and behavior, in both healthy and clinical populations. An intriguing aspect of the phenotypes mediated by these polymorphisms is that they involve a combination of higher propensity to engage in social interactions (and lower social anxiety) with reduced social abilities, a manifestation of pleiotropy that may appear counterintuitive but reflects behavioral phenotypes observed in both Williams syndrome and in a well-established subgroup within autism referred to as ‘active-but-odd’ (e.g., [32]). Our findings thus suggest that healthy populations exhibit comparable, genetically-based, behavioral variation, though in highly-attenuated form.

Limitations of our study include a lack of validation of our Williams syndrome cognitive phenotype index among individuals with Williams syndrome, although data based on self-report in this context may be problematic to obtain and interpret. In addition, larger sample sizes, and testing in additional non-clinical populations (in addition to the autism populations analyzed by Malenfant et al. [18]) would be useful for more-robust interpretation.

The functional bases for cognitive-behavioral effects from GTF2I remains largely unknown. GTF2I codes for the transcription factor TFII-I that is highly expressed in the brain [33], and it belongs to a small paralogous gene family of transcriptional regulators that includes two other genes in the Williams-syndrome region, GTF2IRD1 and GTF2IRD2 [4] that interact with one another in their effects [15]. Of particular interest with regard to the cognitive-behavioral effects of GTF2I is the finding that this gene shows evidence of genomic imprinting effects, with higher expression from the maternally-inherited allele [34]. Williams-syndrome region deletions are thus expected to render gene-expression levels relatively paternally-biased (compared to typically-developing individuals), which may be related to the high levels of social approach and solicitation, coupled with underdeveloped social abilities, in Williams syndrome [35]. Genomic and gene expression studies have also identified a series of changes to GTF2I family genes along the human lineage [4], as well as a striking increase in gene expression of GTF2I in humans compared to related primates [36],[37]. These findings, considered together with our results, imply that the GTF2I gene is also involved in the evolution of complex behavior among humans, in part through its effects on personality traits related to social approach, social anxiety, and social cognition more generally.

Conclusions

The present study provides evidence that polymorphisms in the GTF2I gene mediate social anxiety in relation to social abilities in healthy populations, which, together with convergent results from previous studies, implicates this gene in the hypersocial cognitive-behavioral phenotype of Williams syndrome.

References

  1. Mervis CB, Klein-Tasman BP: Williams syndrome: cognition, personality, and adaptive behavior. Ment Retard Dev Disabil Res Rev. 2000, 6: 148-158. 10.1002/1098-2779(2000)6:2<148::AID-MRDD10>3.0.CO;2-T.

    Article  CAS  PubMed  Google Scholar 

  2. Dykens EM: Anxiety, fears, and phobias in persons with Williams syndrome. Dev Neuropsychol. 2003, 23: 291-316. 10.1080/87565641.2003.9651896.

    Article  PubMed  Google Scholar 

  3. Martens MA, Wilson SJ, Reutens DC: Research review: Williams syndrome: a critical review of the cognitive, behavioral, and neuroanatomical phenotype. J Child Psychol Psychiatry. 2008, 49: 576-608. 10.1111/j.1469-7610.2008.01887.x.

    Article  PubMed  Google Scholar 

  4. Schubert C: The genomic basis of the Williams-Beuren syndrome. Cell Mol Life Sci. 2009, 66: 1178-1197. 10.1007/s00018-008-8401-y.

    Article  CAS  PubMed  Google Scholar 

  5. Morris CA: The behavioral phenotype of Williams syndrome: a recognizable pattern of neurodevelopment. Am J Med Genet C Semin Med Genet. 2010, 154C: 427-431. 10.1002/ajmg.c.30286.

    Article  PubMed  Google Scholar 

  6. Järvinen AM, Bellugi U: What does Williams syndrome reveal about the determinants of social behavior?. Front Hum Neurosci. 2013, 7: 321-10.3389/fnhum.2013.00321.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Järvinen A, Korenberg JR, Bellugi U: The social phenotype of Williams syndrome. Curr Opin Neurobiol. 2013, 23: 414-422. 10.1016/j.conb.2012.12.006.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Somerville MJ, Mervis CB, Young EJ, Seo EJ, del Campo M, Bamforth S, Peregrine E, Loo W, Lilley M, Pérez-Jurado LA, Morris CA, Scherer SW, Osborne LR: Severe expressive-language delay related to duplication of the Williams-Beuren locus. New Engl J Med. 2005, 353: 1694-1701. 10.1056/NEJMoa051962.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Mervis CB, Dida J, Lam E, Crawford-Zelli NA, Young EJ, Henderson DR, Onay T, Morris CA, Woodruff-Borden J, Yeomans J, Osborne LR: Duplication of GTF2I results in separation anxiety in mice and humans. Am J Hum Genet. 2012, 90: 1064-1070. 10.1016/j.ajhg.2012.04.012.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Dixit A, McKee S, Mansour S, Mehta SG, Tanteles GA, Anastasiadou V, Patsalis PC, Martin K, McCullough S, Suri M, Sarkar A: 7q11.23 Microduplication: a recognizable phenotype. Clin Genet. 2013, 83: 155-161. 10.1111/j.1399-0004.2012.01862.x.

    Article  CAS  PubMed  Google Scholar 

  11. Meyer-Lindenberg A, Hariri AR, Munoz KE, Mervis CB, Mattay VS, Morris CA, Berman KF: Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci. 2005, 8: 991-993. 10.1038/nn1494.

    Article  CAS  PubMed  Google Scholar 

  12. Meyer-Lindenberg A, Mervis CB, Berman KF: Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behaviour. Nat Rev Neurosci. 2006, 7: 380-393. 10.1038/nrn1906.

    Article  CAS  PubMed  Google Scholar 

  13. Jabbi M, Kippenhan JS, Kohn P, Marenco S, Mervis CB, Morris CA, Meyer-Lindenberg A, Berman KF: The Williams syndrome chromosome 7q11.23 hemideletion confers hypersocial, anxious personality coupled with altered insula structure and function. Proc Natl Acad Sci USA. 2012, 109: E860-E866. 10.1073/pnas.1114774109.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Young EJ, Lipina T, Tam E, Mandel A, Clapcote SJ, Bechard AR, Chambers J, Mount HTJ, Fletcher PJ, Roder JC, Osborne LR: Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav. 2008, 7: 224-234. 10.1111/j.1601-183X.2007.00343.x.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Palmer SJ, Taylor KM, Santucci N, Widagdo J, Chan YKA, Yeo JL, Adams M, Gunning PW, Hardeman EC: GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members. J Cell Sci. 2012, 125: 5040-5050. 10.1242/jcs.102798.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Li HH, Roy M, Kuscuoglu U, Spencer CM, Halm B, Harrison KC, Bayle JH, Splendore A, Ding F, Meltzer LA, Wright E, Paylor R, Deisseroth K, Francke U: Induced chromosome deletions cause hypersociability and other features of Williams-Beuren syndrome in mice. EMBO Mol Med. 2009, 1: 50-65. 10.1002/emmm.200900003.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Sakurai T, Dorr NP, Takahashi N, McInnes LA, Elder GA, Buxbaum JD: Haploinsufficiency of Gtf2i, a gene deleted in Williams syndrome, leads to increases in social interactions. Autism Res. 2011, 4: 28-39. 10.1002/aur.169.

    Article  PubMed  Google Scholar 

  18. Malenfant P, Liu X, Hudson ML, Qiao Y, Hrynchak M, Riendeau N, Hildebrand MJ, Cohen IL, Chudley AE, Forster-Gibson C, Mickelson ECR, Rajcan-Separovic E, Lewis MES, Holden JJA: Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders. J Autism Dev Disord. 2012, 42: 1459-1469. 10.1007/s10803-011-1389-4.

    Article  PubMed  Google Scholar 

  19. Klein-Tasman BP, Mervis CB, Lord C, Phillips KD: Socio-communicative deficits in young children with Williams syndrome: performance on the autism diagnostic observation schedule. Child Neuropsychol. 2007, 13: 444-467. 10.1080/09297040601033680.

    Article  PubMed  Google Scholar 

  20. Klein-Tasman BP, Phillips KD, Lord C, Mervis CB, Gallo FJ: Overlap with the autism spectrum in young children with Williams syndrome. J Dev Behav Pediatr. 2009, 30: 289-299. 10.1097/DBP.0b013e3181ad1f9a.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Tordjman S, Anderson GM, Botbol M, Toutain A, Sarda P, Carlier M, Saugier-Veber P, Baumann C, Cohen D, Lagneaux C, Tabet AC, Verloes A: Autistic disorder in patients with Williams-Beuren syndrome: a reconsideration of the Williams-Beuren syndrome phenotype. PLoS One. 2012, 7: e30778-10.1371/journal.pone.0030778.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, Chu SH, Moreau MP, Gupta AR, Thomson SA, Mason CE, Bilguvar K, Celestino-Soper PBS, Choi M, Crawford EL, Davis L, Davis Wright NR, Dhodapkar RM, DiCola M, DiLullo NM, Fernandez TV, Fielding-Singh V, Fishman DO, Frahm S, Garagaloyan R, Goh GS, Kammela S, Klei L, Lowe JK, Lund SC, et al: Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011, 70: 863-885. 10.1016/j.neuron.2011.05.002.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Mulle JG, Pulver AE, McGrath JA, Wolyniec PS, Dodd AF, Cutler DJ, Sebat J, Malhotra D, Nestadt G, Conrad DF, Hurles M, Barnes CP, Ikeda M, Iwata N, Levinson DF, Gejman PV, Sanders AR, Duan J, Mitchell AA, Peter I, Sklar P, O’Dushlaine CT, Grozeva D, O’Donovan MC, Owen MJ, Hultman CM, Kähler AK, Sullivan PF, Kirov G, et al: Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biol Psychiatry. 2013, 75: 371-377. 10.1016/j.biopsych.2013.05.040.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E: The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001, 31: 5-17. 10.1023/A:1005653411471.

    Article  CAS  PubMed  Google Scholar 

  25. Cohen AS, Matthews RA, Najolia GM, Brown LA: Toward a more psychometrically sound brief measure of schizotypal traits: introducing the SPQ-brief revised. J Pers Disord. 2010, 24: 516-537. 10.1521/pedi.2010.24.4.516.

    Article  CAS  PubMed  Google Scholar 

  26. Reilly J, Losh M, Bellugi U, Wulfeck B: “Frog, where are you?” Narratives in children with specific language impairment, early focal brain injury, and Williams syndrome. Brain Lang. 2004, 88: 229-247. 10.1016/S0093-934X(03)00101-9.

    Article  PubMed  Google Scholar 

  27. Reilly J, Bernicot J, Vicari S, Lacroix A, Bellugi U: Narratives in Children With Williams Syndrome: A Cross Linguistic Perspective. Perspectives on Language and Language Development: Essays in Honor of Ruth A. Berman. Edited by: Ravid D, Shyldkrot HBZ. 2005, Kluwer, Dordrecht, the Netherlands, 303-312. 10.1007/1-4020-7911-7_22.

    Chapter  Google Scholar 

  28. Fishman I, Yam A, Bellugi U, Mills D: Language and sociability: insights from Williams syndrome. J Neurodev Disord. 2011, 3: 185-192. 10.1007/s11689-011-9086-3.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Dai L, Carter CS, Ying J, Bellugi U, Pournajafi-Nazarloo H, Korenberg JR: Oxytocin and vasopressin are dysregulated in Williams syndrome, a genetic disorder affecting social behavior. PLoS One. 2012, 7: e38513-10.1371/journal.pone.0038513.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S, Bjornsdottir G, Walters GB, Jonsdottir GA, Doyle OM, Tost H, Grimm O, Kristjansdottir S, Snorrason H, Davidsdottir SR, Gudmundsson LJ, Jonsson GF, Stefansdottir B, Helgadottir I, Haraldsson M, Jonsdottir B, Thygesen JH, Schwarz AJ, Didriksen M, Stensbøl TB, Brammer M, Kapur S, Halldorsson JG, Hreidarsson S, Saemundsen E, et al: CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014, 505: 361-366. 10.1038/nature12818.

    Article  CAS  PubMed  Google Scholar 

  31. Burkett K, Graham J, McNeney B: hapassoc: software for likelihood inference of trait associations with SNP haplotypes and other attributes. J Stat Softw. 2006, 16: 1-19.

    Article  Google Scholar 

  32. Scheeren AM, Koot HM, Begeer S: Social interaction style of children and adolescents with high-functioning autism spectrum disorder. J Autism Dev Disord. 2012, 42: 2046-2055. 10.1007/s10803-012-1451-x.

    Article  PubMed  Google Scholar 

  33. Danoff SK, Taylor HE, Blackshaw S, Desiderio S: TFII-I, a candidate gene forWilliams syndrome cognitive profile: parallels between regional expression in mouse brain and human phenotype. Neuroscience. 2004, 123: 931-938. 10.1016/j.neuroscience.2003.08.038.

    Article  CAS  PubMed  Google Scholar 

  34. Collette JC, Chen XN, Mills DL, Galaburda AM, Reiss AL, Bellugi U, Korenberg JR: William’s syndrome: gene expression is related to parental origin and regional coordinate control. J Hum Genet. 2009, 54: 193-198. 10.1038/jhg.2009.5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Crespi BJ: The Strategies of the Genes: Genomic Conflicts, Attachment Theory, and Development of the Social Brain. Brain, Behavior and Epigenetics. Edited by: Petronis A, Mill J. 2011, Springer-Verlag, Heidelberg, Berlin, 143-168. 10.1007/978-3-642-17426-1_8.

    Chapter  Google Scholar 

  36. Preuss TM, Cáceres M, Oldham MC, Geschwind DH: Human brain evolution: insights from microarrays. Nat Rev Genet. 2004, 5: 850-860. 10.1038/nrg1469.

    Article  CAS  PubMed  Google Scholar 

  37. Sikela JM: The jewels of our genome: the search for the genomic changes underlying the evolutionarily unique capacities of the human brain. PLoS Genet. 2006, 2: e80-10.1371/journal.pgen.0020080.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Jinko Graham and Brad McNeney for advice, to Silven Read for technical assistance, and to NSERC for financial support.

Author information

Authors and Affiliations

  1. Department of Biology, Simon Fraser University, 8888 University Drive, Burnaby, V5A 1S6, BC, Canada

    Bernard J Crespi

  2. Department of Psychology, and Neuroscience and Mental Health Institute, University of Alberta, 116 St. and 85 Avenue, Edmonton, T6G 2R3, AB, Canada

    Peter L Hurd

Authors
  1. Bernard J Crespi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter L Hurd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernard J Crespi.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

BC planned the study, PH and BC collected and analyzed the questionnaire data, BC collected and analyzed the SNP data, and PH and BC wrote the manuscript. Both authors read and approved the final manuscript.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crespi, B.J., Hurd, P.L. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population. BMC Neurosci 15, 127 (2014). https://doi.org/10.1186/s12868-014-0127-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12868-014-0127-1

Keywords

BMC Neuroscience

ISSN: 1471-2202

Contact us